Comparison between G R Infraprojects IPO and Glenmark Life Sciences IPO.
G R Infraprojects IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Glenmark Life Sciences IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of G R Infraprojects IPO is up to ₹962.37 Cr whereas the issue size of the Glenmark Life Sciences IPO is up to ₹1,513.60 Cr. The final issue price of G R Infraprojects IPO is ₹837.00 per share and of Glenmark Life Sciences IPO is ₹720.00 per share.
| G R Infraprojects IPO | Glenmark Life Sciences IPO | |
|---|---|---|
| Face Value | ₹5 per share | ₹2 per share |
| Issue Price (Lower) | ₹828.00 per share | ₹695.00 per share |
| Issue Price (Upper) | ₹837.00 per share | ₹720.00 per share |
| Issue Price (Final) | ₹837.00 per share | ₹720.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹42.00 per share | |
| Market Lot Size | 17 shares | 20 shares |
| Fresh Issue Size | 0 shares | 1,47,22,222 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹1,060.00 Cr |
| OFS Issue Size | 1,15,08,704 shares | 63,00,000 shares |
| OFS Issue Size (Amount) | up to ₹962.37 Cr | up to ₹453.60 Cr |
| Issue Size Total | 1,15,08,704 shares | 2,10,22,222 shares |
| Issue Size Total (Amount) | up to ₹962.37 Cr | up to ₹1,513.60 Cr |
G R Infraprojects IPO opens on Jul 07, 2021, while Glenmark Life Sciences IPO opens on Jul 27, 2021. The closing date of G R Infraprojects IPO and Glenmark Life Sciences IPO is Jul 09, 2021, and Jul 29, 2021, respectively.
| G R Infraprojects IPO | Glenmark Life Sciences IPO | |
|---|---|---|
| Anchor Bid Date | Jul 06, 2021 | Jul 26, 2021 |
| Issue Open | Jul 07, 2021 | Jul 27, 2021 |
| Issue Close | Jul 09, 2021 | Jul 29, 2021 |
| Basis Of Allotment (Tentative) | Jul 14, 2021 | Aug 03, 2021 |
| Initiation of Refunds (Tentative) | Jul 15, 2021 | Aug 04, 2021 |
| Credit of Share (Tentative) | Jul 16, 2021 | Aug 05, 2021 |
| Listing date (Tentative) | Jul 19, 2021 | Aug 06, 2021 |
| Anchor Lockin End date 1 | Aug 13, 2021 | Sep 02, 2021 |
| Anchor Lockin End date 2 | Oct 12, 2021 | Nov 01, 2021 |
G R Infraprojects IPO P/E ratio is , as compared to Glenmark Life Sciences IPO P/E ratio of .
| G R Infraprojects IPO | Glenmark Life Sciences IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 88.04 | 100 | ||||
| Promoter Shareholding (Post-Issue) | 86.54 | 82.84 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹8092.87 Cr. | ₹8821.96 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the G R Infraprojects IPO Retail Individual Investors (RII) are offered 39,49,297 shares while in Glenmark Life Sciences IPO retail investors are offered 39,49,297 shares. Qualified Institutional Buyers (QIB) are offered 22,56,741 shares in G R Infraprojects IPO and 42,04,450 shares in Glenmark Life Sciences IPO.
| G R Infraprojects IPO | Glenmark Life Sciences IPO | |
|---|---|---|
| Anchor Investor Reservation | 33,85,110 shares | 63,06,660 shares |
| Market Maker Reservation | ||
| QIB | 22,56,741 shares | 42,04,450 shares |
| NII | 16,92,556 shares | 31,53,334 shares |
| RII | 39,49,297 shares | 73,57,778 shares |
| Employee | 2,25,000 shares | |
| Others | ||
| Total | 1,15,08,704 shares | 2,10,22,222 shares |
G R Infraprojects IPO subscribed 102.58x in total, whereas Glenmark Life Sciences IPO subscribed 44.17x.
| G R Infraprojects IPO | Glenmark Life Sciences IPO | |
|---|---|---|
| QIB (times) | 168.58x | 36.97x |
| NII (times) | 238.04x | 122.54x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 12.57x | 14.63x |
| Employee (times) | 1.37x | |
| Other (times) | ||
| Total (times) | 102.58x | 44.17x |
